Sox Therapeutics, founded in Uppsala 2025, develops innovative and targeted gene therapies to treat malignant brain tumors. The company focuses on therapy-resistant cancer cells, which cause tumor recurrence. The activities are conducted in pharmaceutical development, often in collaborations.
| Website | http://www.soxtherapeutics.se |
| Employees | 3 (1 on RocketReach) |
| Founded | 2025 |
| Industry | Biotechnology Research |
Looking for a particular Sox Therapeutics employee's phone or email?
Annika Johansson is the COO of Sox Therapeutics.
1 people are employed at Sox Therapeutics.